natgillin/translations-raw huggingface dataset:
SYN-BTØ11-1 × DAS-59122-7 × SYN-IR6Ø4-5 × MON-ØØØ21-9;
Plan praćenja učinaka na okoliš:
SYN-BTØ11-1 × DAS-59122-7 × SYN-IR6Ø4-5 × DAS-Ø15Ø7-1;
Plan praćenja učinaka na okoliš u skladu s Prilogom VII.
on the identification of bis(2-ethylhexyl) phthalate (DEHP), dibutyl phthalate (DBP), benzyl butyl phthalate (BBP) and diisobutyl phthalate (DIBP) as substances of very high concern according to Article 57(f) of Regulation (EC) No 1907/2006 of the European Parliament and of the Council
o označivanju bis(2-etilheksil)-ftalata (DEHP), dibutil-ftalata (DBP), benzil butil ftalata (BBP) i diizobutil ftalata (DIBP) kao tvari vrlo zabrinjavajućih svojstava u skladu s člankom 57. točkom (f) Uredbe (EZ) br. 1907/2006 Europskog parlamenta i Vijeća
(notified under document C(2017) 4462)
(priopćeno pod brojem dokumenta C(2017) 4462)
Having regard to Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC [1], and in particular Article 59(9) thereof,
uzimajući u obzir Uredbu (EZ) br. 1907/2006 Europskog parlamenta i Vijeća od 18. prosinca 2006. o registraciji, evaluaciji, autorizaciji i ograničavanju kemikalija (REACH) i osnivanju Europske agencije za kemikalije te o izmjeni Direktive 1999/45/EZ i stavljanju izvan snage Uredbe Vijeća (EEZ) br. 793/93 i Uredbe Komisije (EZ) br. 1488/94 kao i Direktive Vijeća 76/769/EEZ i direktiva Komisije 91/155/EEZ, 93/67/EEZ, 93/105/EZ i 2000/21/EZ [1], a posebno njezin članak 59. stavak 9.,
Bis(2-ethylhexyl) phthalate (DEHP), (EC No 204-211-0, CAS No 117-81-7), dibutyl phthalate (DBP) (EC No 201-557-4, CAS No 84-74-2), benzyl butyl phthalate (BBP) (EC No 201-622-7, CAS No 85-68-7) and diisobutyl phthalate (DIBP) (EC No 201-553-2, CAS No 84-69-5) are included in the candidate list referred to in Article 59(1) of Regulation (EC) No 1907/2006 as substances toxic for reproduction (category 1B) according to Article 57(c) of that Regulation.
bis(2-etilheksil)-ftalat (DEHP), (EC br. 204-211-0, CAS br. 117-81-7), dibutil-ftalat (DBP) (EZ br. 201-557-4, CAS br. 84-74-2), benzil butil ftalat (BBP) (EZ br. 201-622-7, CAS br. 85-68-7) i diizobutil ftalat (DIBP) (EZ br. 201-553-2, CAS br. 84-69-5) uključeni su na popis tvari predloženih za uvrštenje iz članka 59. stavka 1.
Those substances are also listed in Annex XIV to that Regulation.
Uredbe (EZ) br. 1907/2006 kao reproduktivno toksične tvari (kategorija 1.B) u skladu s člankom 57. točkom (c) te Uredbe.
In accordance with Article 59(3) of Regulation (EC) No 1907/2006, on 26 August 2014 Denmark submitted to the European Chemicals Agency (hereinafter referred to as ‘the Agency’) four dossiers in accordance with Annex XV to that Regulation (hereinafter referred to as ‘Annex XV dossiers’) for the identification of DEHP, DBP, BBP and DIBP as substances of very high concern under Article 57(f) of that Regulation due to their endocrine disrupting properties for which there is scientific evidence of probable serious effects to human health or the environment which give rise to an equivalent level of concern to those of other substances listed in paragraphs (a) to (e) of Article 57.
Te su tvari navedene i u Prilogu XIV. toj Uredbi.
When the four Annex XV dossiers were considered by the Member State Committee of the Agency (‘MSC’), they were considered in two parts each, one covering the human health aspects and the other covering the environmental aspects of the dossier, respectively.
U skladu s člankom 59. stavkom 3.
As for the Annex XV dossiers for DBP, BBP and DIBP, the dossier submitter subsequently withdrew the part of its proposal concerning identification of these substances as having endocrine disrupting properties whose effects in relation to the environment give rise to an equivalent level of concern according to Article 57(f) of Regulation (EC) No 1907/2006, in order to further elaborate on the justifications provided in the documentation.
Uredbe (EZ) br. 1907/2006, Danska je 26. kolovoza 2014. podnijela Europskoj agenciji za kemikalije (dalje u tekstu: „Agencija”) četiri dosjea u skladu s Prilogom XV. toj Uredbi (dalje u tekstu: „dokumentacija u skladu s Prilogom XV.”) za označivanje DEHP-a, DBP-a, BBP-a i DIBP-a kao tvari vrlo zabrinjavajućih svojstava u skladu s člankom 57. točkom (f) te Uredbe, zbog svojstava endokrine disrupcije za koje postoje znanstveni dokazi o vjerojatnim ozbiljnim učincima na zdravlje ljudi ili okoliš koji su jednako zabrinjavajući kao i učinci ostalih tvari navedenih u članku 57. točkama od (a) do (e).
On 11 December 2014 the MSC adopted its opinions [2] on the remaining part of the Annex XV dossiers.
Odbor država članica u okviru Agencije razmatrao je dokumentaciju u skladu s Prilogom XV. u dvije skupine po dva dosjea, dva u području zdravlja ljudi i dva u području zaštite okoliša.
The MSC reached a unanimous agreement on the identification of DEHP as having endocrine disrupting properties for which there is scientific evidence of probable serious effects to the environment which give rise to an equivalent level of concern according to Article 57(f) of Regulation (EC) No 1907/2006.
Podnositelj je naknadno povukao dokumentaciju u skladu s Prilogom XV. koja se odnosi na označivanje DBP-a, BBP-a i DIBP-a kao tvari sa svojstvima endokrine disrupcije čiji učinci na okoliš izazivaju jednaku zabrinutost u skladu s člankom 57. točkom (f) Uredbe (EZ) br. 1907/2006, radi dodatne razrade obrazloženja navedenih u dokumentaciji.
Accordingly the Agency amended the DEHP entry in the candidate list on 17 December 2014.
Odbor država članica je 11. prosinca 2014. donio stajalište [2] o preostalom dijelu dokumentacije u skladu s Prilogom XV.
The MSC unanimously acknowledged that for DEHP, BBP, DBP and DIBP there is scientific evidence on the endocrine activity and on the link between this activity and the adverse effects to human health and further, that the substances can be considered endocrine disruptors for human health as they fulfil the WHO/IPCS definition for an endocrine disruptor and the recommendations from the European Commission's Expert Advisory Group for a substance to be identified as an endocrine disruptor.
Odbor država članica postigao je suglasnost o označivanju DEHP-a kao tvari sa svojstvima endokrine disrupcije za koje postoje znanstveni dokazi o vjerojatnim ozbiljnim učincima na okoliš koji izazivaju jednaku zabrinutost u skladu s člankom 57. točkom (f) Uredbe (EZ) br. 1907/2006.
However, the MSC did not reach unanimous agreement on the identification of the four substances under Article 57(f) of Regulation (EC) No 1907/2006 as giving rise to an equivalent level of concern to those of other substances listed in points (a) to (c) of that Article due to endocrine disrupting properties in relation to human health.
U skladu s tim Agencija je 17. prosinca 2014. izmijenila unos DEHP-a na popisu tvari predloženih za uvrštenje.
According to four members of the MSC the effects for human health pointed out in the Annex XV dossiers were the same effects, caused by the same mode of action, as those already taken into account when the substances were included in the candidate list due to their toxicity for reproduction according to Article 57(c) of that Regulation.
Odbor država članica je jednoglasno potvrdio postojanje znanstvenih dokaza o svojstvima endokrine disrupcije DEHP-a, BBP-a, DBP-a i DIBP-a te uzročno-posljedične povezanosti tih svojstava i štetnih učinaka na zdravlje ljudi te da se te tvari mogu smatrati tvarima sa svojstvima endokrine disrupcije zdravlja ljudi jer ispunjavaju uvjete iz definicije endokrinog disruptora Svjetske zdravstvene organizacije i Međunarodnog programa za sigurnost kemikalija, kao i preporuka Stručne savjetodavne skupine Europske komisije o označivanju tvari kao endokrinih disruptora.
On 20 February 2015, pursuant to Article 59(9) of Regulation (EC) No 1907/2006, the MSC referred its opinion to the Commission for a decision on the identification of the four substances as having endocrine disrupting properties for human health giving rise to an equivalent level of concern according to Article 57(f).
No Odbor država članica nije postigao jednoglasan dogovor o označivanju četiri tvari u skladu s člankom 57. točkom (f) Uredbe (EZ) br. 1907/2006 kao tvari koje izazivaju jednaku zabrinutost kao i ostale tvari navedene u istom članku u točkama od (a) do (c), zbog svojstava endokrine disrupcije u odnosu na zdravlje ljudi.
The Commission notes the unanimous agreement in MSC that the four substances have endocrine disrupting properties and that the adverse effects caused by this mode of action are the same effects that led to their classification as toxic for reproduction and their identification as substances of very high concern according to Article 57(c) of Regulation (EC) No 1907/2006.
Četiri člana Odbora istaknula su da su učinci na zdravlje ljudi navedeni u dokumentaciji u skladu s Prilogom XV. isti učinci, uzrokovani istim načinom djelovanja, kao i učinci koji su već uzeti u obzir pri njihovom stavljanju na popis tvari predloženih za uvrštenje zbog njihove reproduktivne toksičnosti u skladu s člankom 57. točkom (c) te Uredbe.
The Commission also notes that the majority of members of the MSC considered that the level of concern of those effects is equivalent to those of substances referred to in Article 57(a) to (e).
Dana 20. veljače 2015.
The Commission notes that Article 57 does not preclude identifying a substance as being of very high concern several times based on more than one intrinsic property causing the same effect on human health.
Odbor država članica je, u skladu s člankom 59. stavkom 9.
Therefore DEHP, BBP, DBP and DIBP should be identified under Article 57(f) as substances of very high concern due to their endocrine disrupting properties for which there is scientific evidence of probable serious effects to human health which give rise to an equivalent level of concern to those of other substances listed in paragraph(s) (a) to (e) of that Article.
Uredbe (EZ) br. 1907/2006, uputio svoje stajalište Komisiji radi odluke o označivanju četiri tvari kao tvari sa svojstvima endokrine disrupcije čiji učinci izazivaju jednaku zabrinutost u skladu s člankom 57. točkom (f).
This Decision is without prejudice to the outcome of the on-going activities related to the definition of criteria for the identification of endocrine disruptors in accordance with the provisions of Regulation (EC) No 1107/2009 of the European Parliament and of the Council [3], and Regulation (EU) No 528/2012 of the European Parliament and of the Council [4].
Komisija navodi jednoglasno stajalište Odbora država članica o tome da četiri tvari imaju svojstva endokrine disrupcije i da su njihovi štetni učinci uzrokovani tim načinom djelovanja jednaki učincima koji su doveli do razvrstavanja među reproduktivno toksične tvari i o njihovom označivanju kao tvarima vrlo zabrinjavajućih svojstava u skladu s člankom 57. točkom (c) Uredbe (EZ) br. 1907/2006.
The measures provided for in this Decision are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006,
Osim toga, Komisija navodi da većina članova Odbora država članica smatra da ti učinci izazivaju jednaku razinu zabrinutosti kao i učinci ostalih tvari navedenih u članku 57. točkama od (a) do (e).
HAS ADOPTED THIS DECISION:
Komisija navodi da se člankom 57. ne isključuje označivanje tvari kao tvari vrlo zabrinjavajućih svojstava nekoliko puta na temelju istog učinka na zdravlje ljudi.
Sole Article
Stoga bi DEHP, DBP, BBP i DIBP trebalo označiti kao tvari vrlo zabrinjavajućih svojstava u skladu s člankom 57. točkom (f) zbog svojstava endokrine disrupcije za koje postoje znanstveni dokazi o vjerojatnim ozbiljnim učincima na zdravlje ljudi koji su jednako zabrinjavajući kao i učinci ostalih tvari navedenih u tom članku u točkama od (a) do (e).
The following substances are identified as substances having endocrine disrupting properties whose effects to human health give rise to an equivalent level of concern according to Article 57(f) of Regulation (EC) No 1907/2006:
Ovom se Odlukom ne dovode u pitanje rezultati aktivnosti u tijeku povezanih s definiranjem kriterija za utvrđivanje endokrinih disruptora u skladu s odredbama Uredbe (EZ) br. 1107/2009 Europskog parlamenta i Vijeća [3], kao i odredbama Uredbe (EU) br. 528/2012 Europskog parlamenta i Vijeća [4].
Bis(2-ethylhexyl) phthalate (DEHP), (EC No 204-211-0, CAS No 117-81-7)
Mjere predviđene ovom Odlukom u skladu su s mišljenjem Odbora osnovanog na temelju članka 133.
Dibutyl phthalate (DBP) (EC No 201-557-4, CAS No 84-74-2)
Uredbe (EZ) br. 1907/2006,
Benzyl butyl phthalate (BBP) (EC No 201-622-7, CAS No 85-68-7)
DONIJELA JE OVU ODLUKU:
Diisobutyl phthalate (DIBP) (EC No 201-553-2, CAS No 84-69-5)
Jedini članak
The entry of the substances specified in paragraph 1 in the candidate list referred to in Article 59(1) of Regulation (EC) No 1907/2006 shall be amended by adding, under ‘Reason for inclusion’, ‘Equivalent level of concern having probable serious effects to human health’.
Sljedeće tvari označuju se kao tvari sa svojstvima endokrine disrupcije čiji učinci na zdravlje ljudi izazivaju jednaku zabrinutost u skladu s člankom 57. točkom (f) Uredbe (EZ) br. 1907/2006:
This Decision is addressed to the European Chemicals Agency.
bis(2-etilheksil)-ftalat (DEHP), (EZ br. 204-211-0, CAS br. 117-81-7),
Done at Brussels, 4 July 2017.
dibutil-ftalat (DBP) (EZ br. 201-557-4, CAS br. 84-74-2),
For the Commission
benzil butil ftalat (BBP) (EZ br. 201-622-7, CAS br. 85-68-7),
Member of the Commission
diizobutil ftalat (DIBP) (EZ br. 201-553-2, CAS br. 84-69-5).
OJ L 396, 30.12.2006, p. 1.
Unos tvari iz stavka 1. na popisu tvari predloženih za uvrštenje iz članka 59. stavka 1.
Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (OJ L 309, 24.11.2009, p. 1).
Uredbe (EZ) br. 1907/2006 mijenja se dodavanjem, pod „razlog uvrštenja”, sljedećeg teksta: „jednaka razina zabrinutosti s vjerojatnim ozbiljnim učincima na zdravlje ljudi”.
Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (OJ L 167, 27.6.2012, p. 1).
Ova je Odluka upućena Europskoj agenciji za kemikalije.
authorising the placing on the market of products containing, consisting of, or produced from genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913 (DAS-24236-5 × DAS-21Ø23-5 × MON-88913-8) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
o odobravanju stavljanja na tržište proizvoda koji sadržavaju genetski modificirani pamuk 281-24-236 × 3006-210-23 × MON 88913 (DAS-24236-5 × DAS-21Ø23-5 × MON-88913-8), sastoje se ili su proizvedeni od njega na temelju Uredbe (EZ) br. 1829/2003 Europskog parlamenta i Vijeća
Having regard to Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified food and feed [1], and in particular Article 7(3) and Article 19(3) thereof,
uzimajući u obzir Uredbu (EZ) br. 1829/2003 Europskog parlamenta i Vijeća od 22. rujna 2003. o genetski modificiranoj hrani i hrani za životinje [1], a posebno njezin članak 7. stavak 3. i članak 19. stavak 3.,
On 12 March 2009, Dow AgroSciences Europe submitted to the competent authority of The Netherlands an application, in accordance with Articles 5 and 17 of Regulation (EC) No 1829/2003, for the placing on the market of foods, food ingredients, and feed containing, consisting of, or produced from 281-24-236 × 3006-210-23 × MON 88913 cotton.
Društvo Dow AgroSciences Europe podnijelo je 12. ožujka 2009. nadležnom tijelu Nizozemske, u skladu s člancima 5. i 17.
The application also covers the placing on the market of 281-24-236 × 3006-210-23 × MON 88913 cotton in products consisting of it or containing it for any other uses than food and feed as any other cotton, with the exception of cultivation.
Uredbe (EZ) br. 1829/2003, zahtjev za stavljanje na tržište hrane, sastojaka hrane i hrane za životinje koji sadržavaju pamuk 281-24-236 × 3006-210-23 × MON 88913, sastoje se ili su proizvedeni od njega.
In accordance with Article 5(5) and Article 17(5) of Regulation (EC) No 1829/2003, the application includes the data and information required by Annexes III and IV to Directive 2001/18/EC of the European Parliament and of the Council [2] and information and conclusions about the risk assessment carried out in accordance with the principles set out in Annex II to Directive 2001/18/EC.
Zahtjev obuhvaća i stavljanje na tržište pamuka 281-24-236 × 3006-210-23 × MON 88913 u proizvodima koji se sastoje od njega ili ga sadržavaju te se, osim za hranu i hranu za životinje, koristi kao i ostali pamuk, osim uzgoja.
It also includes a monitoring plan for environmental effects conforming with Annex VII to Directive 2001/18/EC.
U skladu s člankom 5. stavkom 5. i člankom 17. stavkom 5.
On 8 April 2016, the European Food Safety Authority (‘EFSA’) issued a favourable opinion [3] in accordance with Articles 6 and 18 of Regulation (EC) No 1829/2003.
Uredbe (EZ) br. 1829/2003 zahtjev sadržava podatke i informacije koji su potrebni u skladu s prilozima III. i IV.
It concluded that genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913 is as safe and as nutritious as its conventional counterpart in the context of its intended uses.
Direktivi 2001/18/EZ Europskog parlamenta i Vijeća [2] te informacije i zaključke o procjeni rizika provedenoj u skladu s načelima utvrđenima u Prilogu II.
In its opinion, EFSA considered all the specific questions and concerns raised by the Member States in the context of the consultation of the national competent authorities as provided for by Article 6(4) and Article 18(4) of Regulation (EC) No 1829/2003.
Direktivi 2001/18/EZ.
In its opinion, EFSA also concluded that the environmental monitoring plan, consisting of a general surveillance plan, submitted by the applicant is in line with the intended uses of the products.
Zahtjev sadržava i plan praćenja učinaka na okoliš u skladu s Prilogom VII.
Taking into account those considerations, authorisation should be granted to the products containing, consisting of, or produced from genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913.
Direktivi 2001/18/EZ.
A unique identifier should be assigned to genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913 in accordance with Commission Regulation (EC) No 65/2004 [4].
Europska agencija za sigurnost hrane („EFSA”) izdala je 8. travnja 2016. pozitivno mišljenje [3] u skladu s člancima 6. i 18.
On the basis of the EFSA opinion, no specific labelling requirements other than those provided for in Article 13(1) and Article 25(2) of Regulation (EC) No 1829/2003 appear to be necessary for foods, food ingredients and feed containing, consisting of, or produced from cotton 281-24-236 × 3006-210-23 × MON 88913.
Uredbe (EZ) br. 1829/2003.
However, in order to ensure the use of the products containing or consisting of cotton 281-24-236 × 3006-210-23 × MON 88913 within the limits of the authorisation provided for by this Decision, the labelling of those products, with the exception of food products, should be complemented by a clear indication that the products in question must not be used for cultivation.
Zaključila je da je genetski modificirani pamuk 281-24-236 × 3006-210-23 × MON 88913 jednako siguran i hranjiv kao njegov konvencionalni ekvivalent u kontekstu njegove predviđene namjene.
The authorisation holder should submit annual reports on the implementation and the results of the activities set out in the monitoring plan for environmental effects.
EFSA je u svojem mišljenju uzela u obzir sva specifična pitanja i dvojbe država članica koji su izneseni u okviru savjetovanja s nacionalnim nadležnim tijelima, kako je predviđeno u članku 6. stavku 4. i članku 18. stavku 4.
Those results should be presented in accordance with Commission Decision 2009/770/EC [5].
Uredbe (EZ) br. 1829/2003.
The EFSA opinion does not justify the imposition of specific conditions or restrictions for the placing on the market and/or of specific conditions or restrictions for the use and handling, including post-market monitoring requirements for the use of the food and feed, or of specific conditions for the protection of particular ecosystems/environment and/or geographical areas, as provided for in Article 6(5)(e) and Article 18(5)(e) of Regulation (EC) No 1829/2003.
EFSA je u svojem mišljenju zaključila i da je plan praćenja stanja okoliša koji je dostavio podnositelj zahtjeva i koji se sastoji od općeg plana nadzora u skladu s predviđenim namjenama proizvoda.
All relevant information on the authorisation of the products should be entered in the Community register of genetically modified food and feed referred to in Regulation (EC) No 1829/2003.
Uzimajući u obzir navedeno, potrebno je odobriti proizvode koji sadržavaju genetski modificirani pamuk 281-24-236 × 3006-210-23 × MON 88913, sastoje se ili su proizvedeni od njega.
The Standing Committee on Plants, Animals, Food and Feed has not delivered an opinion within the time-limit laid down by its Chairman.
Genetski modificiranom pamuku 281-24-236 × 3006-210-23 × MON 88913 trebalo bi dodijeliti jedinstveni identifikacijski kôd, kako je predviđeno u Uredbi Komisije (EZ) br. 65/2004 [4].
An implementing act was deemed to be necessary and the chair submitted the draft implementing act to the appeal committee for further deliberation.
Na temelju mišljenja EFSA-e nisu potrebni posebni zahtjevi označivanja za hranu, sastojke hrane i hranu za životinje koja sadržava pamuk 281-24-236 × 3006-210-23 × MON 88913, sastoji se ili je proizvedena od njega, osim onih koji su propisani člankom 13. stavkom 1. i člankom 25. stavkom 2 Uredbe (EZ) br. 1829/2003.
The appeal committee did not deliver an opinion,
Ipak, kako bi se zajamčilo da se proizvodi koji sadržavaju pamuk 281-24-236 × 3006-210-23 × MON 88913 ili se od njega sastoje upotrebljavaju u okviru granica odobrenja predviđenog ovom Odlukom, pri označivanju tih proizvoda, osim prehrambenih proizvoda, trebalo bi jasno istaknuti da se proizvodi u pitanju ne smiju upotrebljavati za uzgoj.
Article 1
Te bi rezultate trebalo dostaviti u skladu s Odlukom Komisije 2009/770/EZ [5].
Genetically modified organism and unique identifier
Uzimajući u obzir mišljenje EFSA-e, nije opravdano uvođenje posebnih uvjeta i ograničenja za stavljanje na tržište i/ili posebnih uvjeta i ograničenja za uporabu i rukovanje, uključujući zahtjeve za nadzor uporabe hrane i hrane za životinje nakon stavljanja na tržište, niti posebnih uvjeta za zaštitu posebnih ekosustava/okoliša i/ili geografskih područja, kako je predviđeno u članku 6. stavku 5. točki (e) i članku 18. stavku 5. točki (e) Uredbe (EZ) br. 1829/2003.
Genetically modified cotton (Gossypium hirsutum L.) 281-24-236 × 3006-210-23 × MON 88913, as specified in point (b) of the Annex to this Decision, is assigned the unique identifier DAS-24236-5×DAS-21Ø23-5×MON-88913-8, in accordance with Regulation (EC) No 65/2004.
Sve relevantne informacije o odobrenju proizvoda trebalo bi upisati u registar Zajednice genetski modificirane hrane i hrane za životinje iz Uredbe (EZ) br. 1829/2003.
Authorisation
Provedbeni akt smatrao se potrebnim i predsjednik Odbora podnio je nacrt provedbenog akta žalbenom odboru na daljnje razmatranje.
The following products are authorised for the purposes of Article 4(2) and Article 16(2) of Regulation (EC) No 1829/2003 in accordance with the conditions set out in this Decision:
Žalbeni odbor nije donio mišljenje,
foods and food ingredients containing, consisting of, or produced from DAS-24236-5×DAS-21Ø23-5×MON-88913-8 cotton;
DONIJELA JE OVU ODLUKU:
feed containing, consisting of, or produced from DAS-24236-5×DAS-21Ø23-5×MON-88913-8 cotton;
Članak 1.